TrialEuropean urology2023

Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial.

Oliver Sartor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.